Thalidomide as an emerging immunotherapeutic agent

Thalidomide first hit the headlines with alarming reports of birth defects after pregnant women took the drug to combat morning sickness. Now, the dru g has been shown to have important immunomodulatory and anti-inflammatory e ffects that may be useful in the treatment of AIDS and cancer.